Notice: This company has been marked as potentially delisted and may not be actively trading. Zafgen (ZFGN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends ZFGN vs. COGT, PCRX, PAHC, NUVB, AVBP, ABCL, QURE, ETNB, PLRX, and CDMOShould you be buying Zafgen stock or one of its competitors? The main competitors of Zafgen include Cogent Biosciences (COGT), Pacira BioSciences (PCRX), Phibro Animal Health (PAHC), Nuvation Bio (NUVB), ArriVent BioPharma (AVBP), AbCellera Biologics (ABCL), uniQure (QURE), 89bio (ETNB), Pliant Therapeutics (PLRX), and Avid Bioservices (CDMO). These companies are all part of the "medical" sector. Zafgen vs. Cogent Biosciences Pacira BioSciences Phibro Animal Health Nuvation Bio ArriVent BioPharma AbCellera Biologics uniQure 89bio Pliant Therapeutics Avid Bioservices Cogent Biosciences (NASDAQ:COGT) and Zafgen (NASDAQ:ZFGN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Do analysts prefer COGT or ZFGN? Cogent Biosciences presently has a consensus target price of $14.83, indicating a potential upside of 89.20%. Given Cogent Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Cogent Biosciences is more favorable than Zafgen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cogent Biosciences 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Zafgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor COGT or ZFGN? In the previous week, Cogent Biosciences had 4 more articles in the media than Zafgen. MarketBeat recorded 4 mentions for Cogent Biosciences and 0 mentions for Zafgen. Cogent Biosciences' average media sentiment score of 0.20 beat Zafgen's score of 0.00 indicating that Cogent Biosciences is being referred to more favorably in the media. Company Overall Sentiment Cogent Biosciences Neutral Zafgen Neutral Do insiders & institutionals have more ownership in COGT or ZFGN? 70.4% of Zafgen shares are held by institutional investors. 5.9% of Cogent Biosciences shares are held by company insiders. Comparatively, 14.2% of Zafgen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, COGT or ZFGN? Zafgen is trading at a lower price-to-earnings ratio than Cogent Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCogent BiosciencesN/AN/A-$192.41M-$2.48-3.16ZafgenN/AN/A-$45.41M-$1.07-3.75 Which has more risk & volatility, COGT or ZFGN? Cogent Biosciences has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Comparatively, Zafgen has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Does the MarketBeat Community prefer COGT or ZFGN? Zafgen received 58 more outperform votes than Cogent Biosciences when rated by MarketBeat users. However, 70.69% of users gave Cogent Biosciences an outperform vote while only 68.59% of users gave Zafgen an outperform vote. CompanyUnderperformOutperformCogent BiosciencesOutperform Votes28770.69% Underperform Votes11929.31% ZafgenOutperform Votes34568.59% Underperform Votes15831.41% Is COGT or ZFGN more profitable? Zafgen's return on equity of -51.34% beat Cogent Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Cogent BiosciencesN/A -112.55% -60.44% Zafgen N/A -51.34%-34.55% SummaryCogent Biosciences beats Zafgen on 8 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZFGN vs. The Competition Export to ExcelMetricZafgenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$150.26M$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E Ratio-4.1810.5990.0517.18Price / SalesN/A196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / Book2.975.094.784.78Net Income-$45.41M$151.83M$120.31M$225.60M Zafgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZFGNZafgenN/A$4.01+0.8%N/A+4.4%$150.26MN/A-4.1838High Trading VolumeCOGTCogent Biosciences2.1944 of 5 stars$8.31+2.0%$14.83+78.5%+42.5%$917.92MN/A-3.2980PCRXPacira BioSciences3.7482 of 5 stars$19.87+0.1%$23.50+18.3%-42.4%$917.40M$674.98M-9.78720Gap DownPAHCPhibro Animal Health4.1512 of 5 stars$22.64-0.1%$19.00-16.1%+90.4%$916.99M$1.05B52.561,940Analyst ForecastNUVBNuvation Bio2.3873 of 5 stars$2.69+3.1%$6.60+145.4%+81.7%$905.37MN/A0.0060News CoverageGap DownAVBPArriVent BioPharma0.9574 of 5 stars$26.51-0.8%$36.80+38.8%N/A$893.31MN/A0.0040News CoveragePositive NewsABCLAbCellera Biologics1.9861 of 5 stars$2.88+2.5%$8.67+200.9%-49.9%$850.65M$32.96M-4.92586News CoverageQUREuniQure3.5184 of 5 stars$17.40+13.0%$32.13+84.6%+171.2%$848.13M$28.59M-3.36500Analyst ForecastHigh Trading VolumeETNB89bio1.7364 of 5 stars$7.90+2.7%$30.33+284.0%-25.9%$838.40MN/A-2.6440News CoveragePLRXPliant Therapeutics3.3664 of 5 stars$13.72+3.2%$40.50+195.2%-19.9%$834.86M$1.58M0.0090CDMOAvid Bioservices2.4366 of 5 stars$12.37+0.2%$12.25-1.0%+91.9%$791.22M$150.45M-5.17371 Related Companies and Tools Related Companies COGT Alternatives PCRX Alternatives PAHC Alternatives NUVB Alternatives AVBP Alternatives ABCL Alternatives QURE Alternatives ETNB Alternatives PLRX Alternatives CDMO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZFGN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZFGN Stock Alerts